Form 8-K VERTEX PHARMACEUTICALS For: Feb 05

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. ELV
10. NDAQ

Go back to Form 8-K VERTEX PHARMACEUTICALS For: Feb 05

Vertex (VRTX) PT Raised to $220 at Cowen

February 6, 2019 7:52 AM EST

Cowen analyst Phil Nadeau raised the price target on Vertex (NASDAQ: VRTX) to $220.00 (from $210.00) while maintaining a Outperform rating.

The analyst commented, "VRTX reported Q4 CF franchise revenue of $868.2MM vs consensus of $818.8MM, non-GAAP EPS of $1.30 vs. consensus of $1.08. 2019 revenue guidance... More

Maxim Group Downgrades Vertex (VRTX) to Hold

February 6, 2019 7:45 AM EST

Maxim Group analyst Jason McCarthy downgraded Vertex (NASDAQ: VRTX) from Buy to Hold.

The analyst highlighted:

Vertex reported 4Q18 with cystic fibrosis (CF) revenue of $868M, representing sequential growth of 11% and beating consensus of $816M; the results include Kalydeco revenue of $259M vs. $250.5M... More